The ELEVATE Study shows that atogepant effectively prevents episodic migraine.

Published Date: 24 Apr 2023

Atogepant (Qulipta) performed better than a placebo in the ELEVATE study for preventing episodic migraine in patients who were resistant to other treatments.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Risk of a second cancer after early breast cancer is low, say new findings

2.

Study suggests exercise could reduce breast cancer recurrence

3.

Study recommends new grading system for invasive squamous cell carcinoma of the lung

4.

Distribution of fat could influence cancer risk, study suggests

5.

Algorithm that predicts pancreatic cancer metastasis could help avoid unnecessary surgeries


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot